reference/20257100

Predicate	Object
contentType	Journal Article\|Review
endingPage	162
issn	1178-6965
pageRange	155-162
publicationName	Journal of Asthma and Allergy
startingPage	155
bibliographicCitation	Maselli DJ, Velez MI, Rogers L. Reslizumab in the management of poorly controlled asthma: the data so far. J Asthma Allergy. 2016;9():155–62. PMID: 27621657; PMCID: PMC5012840.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea83ca99e9a97ac6d071abf01f491b9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa199ca0124f282c0d5c36e124f8becc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cba0a4fd46df4615bc0951cb3d033198
date	201608
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5012840 https://pubmed.ncbi.nlm.nih.gov/27621657 https://doi.org/10.2147/jaa.s94164
isPartOf	https://portal.issn.org/resource/ISSN/1178-6965 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38582
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Reslizumab in the management of poorly controlled asthma: the data so far
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6868 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6985 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fee377b7382874724b5dd6d1ce1612cc

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347910352

Total number of triples: 26.